Metoprolol Al (Metoprolol Tartrate)

Metoprolol tartrate is a selective β1‑adrenergic blocker used in cardiovascular conditions.

• Hypertension: lowers blood pressure by reducing cardiac output and renin release.
• Angina pectoris: decreases myocardial oxygen demand, relieving chest pain.
• Post‑myocardial infarction: improves survival by limiting adverse cardiac remodeling.
• Chronic heart failure: enhances ventricular function and reduces hospitalisation risk.
• Cardiac arrhythmias: controls heart rate in atrial and ventricular rhythm disorders.

• Metoprolol tartrate selectively antagonises β1‑adrenergic receptors in the heart, leading to decreased heart rate, reduced myocardial contractility, and lower renin secretion from the kidneys. These actions collectively diminish cardiac workload and systemic vascular resistance, resulting in lowered blood pressure and improved cardiac efficiency.

Metoprolol tartrate may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Fatigue or tiredness.
• Dizziness or light‑headedness.
• Bradycardia (slow heart rate).
• Cold extremities or peripheral vasoconstriction.

Serious or Rare Side Effects

• Severe bradycardia or heart block.
• Marked hypotension.
• Bronchospasm, especially in patients with asthma.
• Allergic reactions such as rash, angioedema, or anaphylaxis.
• Depression or mood changes.
• Worsening heart failure.

Before initiating therapy, clinicians should consider several safety measures.

• Monitor blood pressure: check regularly to avoid excessive hypotension.
• Assess heart rate: ensure rate remains above safe thresholds.
• Use caution in asthma or chronic obstructive pulmonary disease: β1‑selectivity may not fully prevent bronchospasm.
• Review concomitant medications: especially other AV‑node blockers or CYP2D6 inhibitors.
• Adjust dose in renal impairment: reduced clearance may require lower dosing.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Metoprolol tartrate can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

• Verapamil or diltiazem: combined AV‑node blockade may cause severe bradycardia.
• Clonidine abrupt withdrawal: may precipitate hypertensive crisis.
• Insulin or oral hypoglycemics: beta‑blockade can mask hypoglycaemia symptoms.
• Strong CYP2D6 inhibitors (e.g., fluoxetine, quinidine): increase metoprolol plasma levels.

Moderate Interactions (Monitor Closely)

• Diuretics: may enhance hypotensive effect.
• NSAIDs: can reduce antihypertensive efficacy.
• Calcium channel blockers (e.g., amlodipine): additive blood pressure lowering.
• Antidiabetic agents: monitor glucose control.
• Other antihypertensives: titrate dose to avoid excessive blood pressure drop.